Korro Bio Inc — Balance Sheet (NASDAQ:KRRO) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 264.72 M185.36 M121.24 M221.66 M226.24 M Total liabilities 72.23 M54.53 M52.04 M51.75 M65.83 M Total equity 192.49 M130.82 M69.19 M169.91 M160.41 M Total liabilities & shareholders' equities 264.72 M185.36 M121.24 M221.66 M226.24 M Total debt ————— Net debt —————

新闻

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Clear Street因高氨血症项目潜力上调Korro Bio股票评级

Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential

Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?

H.C. Wainwright将Korro Bio股票评级上调至"买入"，看好新药潜力

Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential

派珀·桑德勒上调Korro Bio评级至增持，看好UCD疗法

Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment

Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential

Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28

William Blair重申Korro Bio股票市场表现评级

雷蒙德詹姆斯维持Korro Bio股票"市场表现"评级